Kadimastem
Business Services · Israel · 11-50 Employees
View Company Info for Free
Overview
Headquarters
7 Pinhas Sapir, Ness Ziona, Central Dist...Phone Number
+972 737971600Website
www.kadimastem.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Kadimastem
Kadimastem is a clinical stage biotechnology company based in Israel, specializing in regenerative medicine and cell therapy. The company focuses on developing innovative treatments for incurable diseases, including diabetes and ALS, using a unique platform for off-the-shelf cell-based products. Kadimastem aims to become a global leader in cell therapy, with a commitment to helping millions of patients worldwide. Founded in 2009, the company leverages patented technology developed at the Weizmann Institute of Science.Explore more
Kadimastem Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Kadimastem your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Kadimastem
Check out if Kadimastem is spiking on competitors!
Product Launch: Get notified when Kadimastem launches new products
Check if Kadimastem has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Kadimastem has new funding data
Kadimastem, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Kadimastem recently announced quarterly report
Click to see if Kadimastem had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Kadimastem is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Kadimastem is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Kadimastem.
Kadimastem Tech Stack
A closer look at the technologies used by Kadimastem
See more technologies
Kadimastem News & Media
NLS Pharmaceutics Ltd. and Kadimastem Ltd. Announce Completion of Merger
Combined Company Re-Named NewcelX Ltd., to Commence Trading on the Nasdaq Capital Market on October 31, 2025 under the Ticker Symbol "NCEL" ZURICH and NESS ZIONA, Israel , Oct. 30, 2025 /PRNewswire/ -- NewcelX Ltd. ("NewcelX" or the "Company") completed the previously announced merger...NLS Pharmaceutics and Kadimastem Highlight Continued BIRD Foundation Support for ITOL-102 Diabetes Program Following Merger
ZURICH, Oct. 29, 2025 /PRNewswire/ -- NLS Pharmaceutics Ltd. (Nasdaq: NLSP) ("NLS" or the "Company"), a biopharmaceutical company focused on developing innovative therapies for central nervous system and neurodegenerative disorders, and Kadimastem Ltd. (TASE: KDST) ("Kadimastem"), a...NLS Pharmaceutics Ltd. Announces 1-for-10 Reverse Share Split and Name Change in Connection with Proposed Merger with Kadimastem
ZURICH, Oct. 29, 2025 /PRNewswire/ -- NLS Pharmaceutics Ltd. (NASDAQ: NLSP) (NASDAQ: NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system...NLS Pharmaceutics and Kadimastem Announce Completion of Material Conditions Precedent for Merger Transaction and Delisting Date of Kadimastem's Shares
ZURICH and NESS ZIONA, Israel, Oct. 29, 2025 /PRNewswire/ -- NLS Pharmaceutics Ltd. (NASDAQ: NLSP) (NASDAQ: NLSPW) ("NLS" or the "Company") and Kadimastem Ltd. (TASE: KDST) ("Kadimastem") today announced that, following the receipt of Nasdaq's approval for the listing of the Company's...
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Kadimastem
Sign Up For FreeTo access detailed company insights
Kadimastem is a clinical stage biotechnology company based in Israel, specializing in regenerative medicine and cell therapy. The company focuses on developing innovative treatments for incurable diseases, including diabetes and ALS, using a unique platform for off-the-shelf cell-based products. Kadimastem aims to become a global leader in cell the... Read More
